Diagnosis of myocardial infarction Circulatory System
Conditions
Interventions
Blood collection study for testing on prototype point-of-care in vitro diagnostic platform.
Participants are first consented to take additional blood samples. They are given up to 3 hours to review t
Sponsors
Psyros Diagnostics
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Capacity to give consent 2. >18 years of age 3. Presentation at ED with chest pains and symptoms of myocardial infarction 4. Measured troponin concentration > 10 ng/L in previous 24 hours.
Exclusion criteria
Exclusion criteria: 1. Age <18 years 2. Inability to give consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The concentration of troponin in the blood sample is measured 10 times to estimate the imprecision of the prototype device being tested. Similarly, the concentration of troponin is measured in the corresponding plasma sample 10 times to estimate the imprecision in the measurement. The measured concentration in the blood and plasma samples from all patients are compared to estimate the degree of correlation. Blood samples are taken at a single timepoint. | — |
Secondary
| Measure | Time frame |
|---|---|
| The measured hematocrit on the prototype device is compared to the measurement on a hematocrit centrifuge to estimate the correlation. Blood samples are taken at a single timepoint. | — |
Countries
England, United Kingdom
Contacts
Public ContactSteve Ross
Outcome results
None listed